Latham & Watkins Advises Codexis on US$60 Million Term Loan Facility

Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, has announced it has entered into a US$60 million senior secured term loan agreement with Trinity Capital Inc. (NYSE: TRIN), a leading provider of flexible capital solutions for life sciences and healthcare industries. The company used the proceeds of the first tranche of this transaction to retire the debt that was held by Innovatus Life Sciences Lending Fund I, LP.

Latham & Watkins LLP represented Codexis in the transaction with a finance team led by New York partner Seniz Yakut, with associates Ben Bussmann and Jolena Sun, and assistance from LamPhuong Le. Advice was also provided on corporate matters by Bay Area partner John Williams, with associate Taleah Tyrell; on tax matters by Bay Area partner Grace Lee, with assistance from Francis Shih; on UCC matters by Los Angeles counsel Emily Leong Yu; on intellectual property matters by Bay Area partner Kate Hillier; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler; and on healthcare matters by Bay Area partner Betty Pang and Washington, D.C. counsel Chad Jennings.